West Pharmaceutical Services Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $968.5M | $3.29B | $667.7M |
| Jun 2022 | $937.3M | $3.36B | $718.5M |
| Sep 2022 | $846.0M | $3.32B | $729.0M |
| Dec 2022 | $931.9M | $3.62B | $894.3M |
| Mar 2023 | $947.4M | $3.72B | $886.3M |
| Jun 2023 | $922.9M | $3.67B | $796.3M |
| Sep 2023 | $886.5M | $3.75B | $898.6M |
| Dec 2023 | $948.5M | $3.83B | $853.9M |
| Mar 2024 | $921.7M | $3.60B | $601.8M |
| Jun 2024 | $912.6M | $3.49B | $446.2M |
| Sep 2024 | $923.0M | $3.68B | $490.9M |
| Dec 2024 | $961.1M | $3.64B | $484.6M |
| Mar 2025 | $935.1M | $3.62B | $404.2M |
| Jun 2025 | $1.02B | $3.95B | $509.7M |
| Sep 2025 | $1.05B | $4.11B | $628.5M |
| Dec 2025 | $1.09B | $4.27B | $791.3M |
| Mar 2026 | $1.12B | $4.11B | $521.4M |
| Jun 2026 | $1.09B | $4.08B | $435.8M |